Single-Domain Antibody Detection of Dimeric Peptides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting multimeric peptides, such as dimeric peptides, in neurodegenerative diseases are hindered by the difficulty in characterizing poorly defined multimers and the interference of heterophilic antibodies, leading to false positive results.
Innovation Solution
A method utilizing single-domain antibodies, specifically a carrier material antibody conjugate and a single domain detection antibody with a detection marker, to reliably detect multimeric peptides by forming a complex and recognizing the same epitope, thereby reducing cross-reacting heterophilic antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibodies are used for detecting multimeric peptides, then the detection can be performed, but heterophilic antibodies cause false positive results and reliability is reduced
Solution Approach 1:
The patent changes the fundamental parameter of the antibody structure from conventional multi-domain antibodies to single-domain antibodies (nanobodies). This structural parameter change eliminates heterophilic binding capability while maintaining specificity for the target epitope, thereby resolving the contradiction between detection reliability and heterophilic interference
Solution Approach 2:
The patent extracts only the essential functional domain (the variable domain) from the conventional antibody structure, discarding the constant regions that mediate heterophilic interactions. This extraction results in single-domain antibodies that retain epitope specificity but lose the ability to cross-react with heterophilic antibodies
2Reliability
If single-domain antibodies are used to detect multimeric peptides, then heterophilic antibody interference is reduced, but the method complexity increases due to the need for carrier material antibody conjugates
Solution Approach 1:
The patent introduces a carrier material (such as beads or plates) as an intermediary element that facilitates the detection process. The carrier material serves as a platform for immobilizing the single-domain antibody and enabling signal detection, thereby simplifying the overall assay architecture despite the use of single-domain antibodies
3Measurement precision
If conventional antibodies are used, then the detection can be performed with standard protocols, but sensitivity to cross-reacting substances leads to false test results
Solution Approach 1:
The patent changes the antibody structural parameter from conventional to single-domain, which fundamentally alters the binding characteristics. This parameter change reduces sensitivity to cross-reacting substances while maintaining high precision for the target analyte, resolving the contradiction between measurement precision and cross-reactivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the reliability of detecting multimeric peptides by minimizing false positives and improving sensitivity, allowing for accurate detection of dimeric peptides within multimeric protein agglomerates.
Implementation Method 1
a single domain carrier antibody specific for the first peptide monomer is bound... the single domain carrier antibody on the first peptide monomer and the single domain detection antibody on the second peptide monomer recognize the same epitope
Implementation Method 2
a single domain detection antibody specific for the second peptide monomer comprising a detection marker... the single domain carrier antibody on the first peptide monomer and the single domain detection antibody on the second peptide monomer recognize the same epitope
Data Source
AI summary
A method detects a multimeric, preferably dimeric, peptide containing a first and a second peptide monomer in a sample. The method includes providing a carrier material antibody conjugate comprising a carrier material to which a single domain carrier antibody specific for the first peptide monomer is bound; contacting the sample with the carrier material antibody conjugate, wherein a complex is formed between the carrier material antibody conjugate and the dimeric peptide, contacting the complex with a single domain detection antibody specific for the second peptide monomer comprising a detection marker, wherein the single domain detection antibody binds to the complex, wherein the single domain carrier antibody on the first peptide monomer and the single domain detection antibody on the second peptide monomer recognize the same epitope, and detecting the dimeric peptide using the detection marker. Such a method allows the targeted detection of multimeric or dimeric peptides in a sample.